Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06689930 · ClinicalTrials.gov registry record · NA

Community-based Implementation of Adapted STAC

A NA study of Hypertension and Blood Pressure, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT06689930: Recruiting NA study of Hypertension and Blood Pressure, sponsored by University of Wisconsin, Madison.

NCT06689930 is a NA study of Hypertension and Blood Pressure that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 46 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06689930, a NA study of Hypertension and Blood Pressure, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

This study is being done to adapt the Staying Healthy After Childbirth (STAC) intervention for implementation among Black Women and Birthing Persons (WBP).

Primary Outcome

Barriers to implementation of A-STAC in CBOs will be investigated via qualitative analysis of interviews and focus groups with STAC-CAB members. All feedback regarding barriers will be coded for themes summarized by participant count.

Interventions

  • OTHER PDSA Cycles

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2025-05-22
Est. Completion 2026-09
Phase NA
University of Wisconsin, Madison

1,039 total trials

What NCT06689930 shows while recruiting

NCT06689930 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which PDSA Cycles is the first listed.

NCT06689930 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06689930 about?

NCT06689930 is a clinical study titled "Community-based Implementation of Adapted STAC". This study is being done to adapt the Staying Healthy After Childbirth (STAC) intervention for implementation among Black Women and Birthing Persons (WBP).

What is the current status of trial NCT06689930?

This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2025-05-22. Estimated completion is 2026-09.

What conditions does trial NCT06689930 study?

This clinical trial studies the following conditions: Hypertension, Blood Pressure, Pregnancy Related, Health Equity.

What interventions are being tested in trial NCT06689930?

The interventions under investigation include: PDSA Cycles (OTHER).

Who is sponsoring clinical trial NCT06689930?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06689930 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06689930's enrollment target sits among peer trials

46 378th of 470 higher than 92 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06689930, the US trial registry maintained by the National Library of Medicine. NCT06689930 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.